Zacks Research Issues Optimistic Outlook for NKTR Earnings
Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Zacks Research boosted their Q1 2025 earnings per share estimates for Nektar Therapeutics in a research note issued on Wednesday, April 2nd. Zacks Research analyst K. Das now expects that the biopharmaceutical company will post earnings of ($0.17) per share for the quarter, up from their prior forecast […]
Nektar Therapeutics (NASDAQ:NKTR – Free Report) – Zacks Research boosted their Q1 2025 earnings per share estimates for Nektar Therapeutics in a research note issued on Wednesday, April 2nd. Zacks Research analyst K. Das now expects that the biopharmaceutical company will post earnings of ($0.17) per share for the quarter, up from their prior forecast […]
